Kumar Singh Saikatendu

Author

Also Known As

Anderson, Annaliesa, K. Saikatendu, K.S. Saikatendu, K.S. saikatendu, Kumar S. Saikatendu, Kumar Saikatendu, Kumar Singh Saikatendu, Michaelides, Michael, Saikatendu, Kumar, Saikatendu, Kumar Singh

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Takeda (United States)Scripps Research Institute University of North Carolina at Chapel Hill Novartis Institutes for BioMedical Research University of Oxford

About

Kumar Singh Saikatendu is an author at Takeda (United States) specializing in medicine, molecular biology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.6K
2	Natural Sciences	9	9	1.4K
3	Biochemistry	5	5	931
4	Cell Biology	2	2	191
5	Biomolecular Engineering	1	1	125

Kumar Singh Saikatendu

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Severe acute respiratory syndrome coronavirus papain-like protease: Structure of a viral deubiquitinating enzyme Kiira Ratia, Kumar Singh Saikatendu, Bernard D. Santarsiero, Proceedings of the National Academy of Sciences Protein AssemblyViral PathogenesisMolecular BiologyViral Structural ProteinVirus Structure	2006	430
Structural Basis of Severe Acute Respiratory Syndrome Coronavirus ADP-Ribose-1″-Phosphate Dephosphorylation by a Conserved Domain of nsP3 Kumar Singh Saikatendu, Jeremiah S. Joseph, Vanitha Subramanian, Structure Virus StructureViral ReplicationBiochemistryViral Polymerase StructureConserved Domain	2005	217
Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3 Benjamin W. Neuman, Jeremiah S. Joseph, Kumar Singh Saikatendu, Journal of Virology Viral ReplicationViral PathogenesisImmunologyMolecular BiologyViral Structural Protein	2008	191
Progress towards a public chemogenomic set for protein kinases and a call for contributions David H. Drewry, Carrow I. Wells, David Andrews, PLoS ONE Drug TargetPublic Chemogenomic SetMolecular BiologyTumor BiologyReceptor Tyrosine Kinase	2017	166
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors Melissa L. Boby, D. Fearon, Matteo P. Ferla, Science	2023	158
Ribonucleocapsid Formation of Severe Acute Respiratory Syndrome Coronavirus through Molecular Action of the N-Terminal Domain of N Protein Kumar Singh Saikatendu, Jeremiah S. Joseph, Vanitha Subramanian, Journal of Virology	2007	151
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma Kazuhide Nakayama, Magdalena M. Szewczyk, Carlo dela Seña, Oncotarget	2018	135
Crystal Structure of Nonstructural Protein 10 from the Severe Acute Respiratory Syndrome Coronavirus Reveals a Novel Fold with Two Zinc-Binding Motifs Jeremiah S. Joseph, Kumar Singh Saikatendu, Vanitha Subramanian, Journal of Virology Crystal StructureViral ReplicationViral Polymerase StructureViral Polymerase MechanismViral Pathogenesis	2006	125
Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 <i>H</i> -pyrazolo[3,4- <i>c</i> ]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure–Kinetic Relationships Masato Yoshikawa, Morihisa Saitoh, Taisuke Katoh, Journal of Medicinal Chemistry	2018	115
The Kinase Chemogenomic Set (KCGS): An Open Science Resource for Kinase Vulnerability Identification Carrow I. Wells, Hassan Al‐Ali, David Andrews, International Journal of Molecular Sciences Drug TargetSelective Kinase InhibitorsMolecular BiologyBioinformatics DatabaseTumor Biology	2021	105

Page 1